Andrew Peter THOMAS

NOVEL COMPOUNDS

N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof

Quinazoline derivatives as VEGF inhibitors

PYRAZOLE COMPOUNDS 436

PYRIMIDINE DERIVATIVES FOR THE INHIBITION OF IGF-IR TYROSINE KINASE ACTIVITY

NOVEL COMPOUNDS 747

N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof

Novel Compounds

Quinazoline derivatives as VEGF inhibitors

4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer

2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors

Pyrimidine derivatives possessing cell-cycle inhibitors activity

Cinnoline derivatives and use as medicine

4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity

Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation

Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation

Pyrimidine compounds

Quinazoline derivatives and pharmaceutical compositions containing them

2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors

Pyrimidine derivatives

Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity

4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases

Pyrimidine compounds

Quinazoline derivatives and pharmaceutical compositions containing them

Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivatives